Title | Heart Disease and Erectile Dysfunction [electronic resource] / edited by Robert A. Kloner |
---|---|
Imprint | Totowa, NJ : Humana Press : Imprint: Humana Press, 2004 |
Connect to | http://dx.doi.org/10.1007/978-1-59259-748-2 |
Descript | X, 300 p. online resource |
1 Physiology of Erection and Causes of Erectile Dysfunction -- 2 Erectile Dysfunction: The Scope of the Problem -- 3 Erectile Dysfunction and Cardiovascular Risk Factors -- 4 Psychologic Aspects of Erectile Dysfunction in Heart Patients -- 5 Management of Erectile Dysfunction: An Overview -- 6 Sildenafil Citrate and the Nitric Oxide/Cyclic Guanosine Monophosphate Signaling Pathway -- 7 Phosphodiesterase-5 Inhibition: Importance to the Cardiovascular System -- 8 The Hemodynamics of Phosphodiesterase-PDE5 Inhibitors -- 9 Cardiovascular Safety of Phosphodiesterase-5 Inhibitors -- 10 Effect of Phosphodiesterase-5 Inhibition on Coronary Blood Flow in Experimental Animals -- 11 Safety and Hemodynamic Effects of Sildenafil in Patients With Coronary Artery Disease -- 12 Cardiovascular Effects of Nonphosphodiesterase-5 Inhibitor Erectile Dysfunction Therapies -- 13 Potential Cardiac Applications of Phosphodiesterase Type-5 Inhibition -- 14 The Physiologic Cost of Sexual Activity -- 15 Sexual Activity As a Trigger of Myocardial Infarction/Ischemia: Implications for Treating Erectile Dysfunction -- 16 Sex After Cardiac Events and Procedures: Counseling From the Cardiovascular Specialistโs Perspective -- 17 American College of Cardiology/American Heart Association Guidelines on the Use of Sildenafil in Patients With Cardiovascular Disease -- 18 Risk of Heart Attack After Sexual Activity: The Princeton Guidelines and Their Rationale